Labshake search
Citations for R&D Systems :
101 - 150 of 2683 citations for Recombinant Human Long Arg3 Insulin like Growth Factor I since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... 10 ng/ml Epidermal Growth Factor (EGF) (R&D systems), 10%(v/v ...
-
bioRxiv - Bioengineering 2023Quote: ... fibroblast growth factor (FGF) (R&D Systems, #233-FB/CF), vascular endothelial growth factor (VEGF ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 1ng/ml basic fibroblast growth factor (R&D Systems). MSC used in experiments were from passage 4 – 5 ...
-
bioRxiv - Biophysics 2023Quote: ... 50 ng/ml epidermal growth factor (EGF) (R&D Systems), 25 ng/ml hepatocyte growth factor (HGF ...
-
bioRxiv - Immunology 2023Quote: ... fibroblast growth factor-2 (FGF-2;20ng/mL;R&D systems) and Platelet-derived growth factor (PDGF-AA;20ng/mL;R&D systems ...
-
bioRxiv - Neuroscience 2021Quote: ... The neural medium was supplemented with 10 ng/mL epidermal growth factor (PreproTech, AF-100-15) and 10 ng/mL basic fibroblast growth factor (R&D Systems, 234-FSE-025) and changed daily until day 12 ...
-
bioRxiv - Molecular Biology 2022Quote: ... The neural medium was supplemented with 10 ng/mL epidermal growth factor (PreproTech AF-100-15) and 10 ng/mL basic fibroblast growth factor (R&D Systems 234-FSE-025). From day 6 to day 10 the medium was changed everyday until the appearance of rosettes ...
-
bioRxiv - Bioengineering 2020Quote: ... human insulin was obtained from R&D Systems, Streptozotocin (STZ ...
-
bioRxiv - Physiology 2020Quote: Recombinant human Mfge8 and recombinant human laminin subunit alpha-1 were purchased from R&D Systems, www.rndsystems.com ...
-
bioRxiv - Cell Biology 2021Quote: ... Spain) and supplemented with each one of the following combinations of growth factors: (i) 100 ng/ml Act A (R&D Systems, UK), (ii ...
-
bioRxiv - Microbiology 2024Quote: ... Monocytes were differentiated into hMDMs for at least 7 days in complete medium containing 10 ng.mL-1 of recombinant human macrophage colony-stimulating factor (rhM-CSF; R&D systems).
-
bioRxiv - Cell Biology 2022Quote: Human recombinant JAG1 (R&D System) was fluorescently labeled with Alexa Fluor™ 488 Microscale Protein Labeling Kit (Thermo Scientific ...
-
bioRxiv - Microbiology 2021Quote: ... recombinant human IFNγ (R&D Systems) was also added at varying concentrations ...
-
bioRxiv - Cancer Biology 2020Quote: Recombinant human GDF15 (R&D Systems, Minneapolis ...
-
bioRxiv - Developmental Biology 2019Quote: ... recombinant human BMP4 (R&D Systems) or CHIR-99201 (Wako) ...
-
bioRxiv - Bioengineering 2019Quote: ... recombinant human Wnt7a (R&D systems) reconstituted in PBS was added to the PEG-4MAL precursor solution ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant human MBL (R&D systems) was reconstituted in PBS and serially diluted from 10μg/ml by two-fold dilution ...
-
bioRxiv - Physiology 2022Quote: ... Recombinant human WNT3A (R&D Systems) and recombinant human Norrin (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... recombinant human BMP4 (R&D Systems) was added at 1.5 nM (55 ng/ml)7 ...
-
bioRxiv - Bioengineering 2024Quote: ... Recombinant human VEGF (R&D Systems) was added to the basal media at 20 ng/mL immediately prior to cell treatment ...
-
bioRxiv - Molecular Biology 2021Quote: ... and 50 ng/ml epidermal growth factor (EGF) (R&D Systems). Differentiation medium is CMGF(+ ...
-
bioRxiv - Cell Biology 2019Quote: ... 10 ng/mL basic fibroblast growth factor (bFGF; R&D systems), and 10 ng/mL epidermal growth factor (EGF ...
-
bioRxiv - Cancer Biology 2019Quote: ... and epidermal growth factor (EGF) (R&D Systems 40ng/mL each), was added to a total volume of 10 mL prior to spinning (1200 rpm at 5 min) ...
-
bioRxiv - Bioengineering 2021Quote: ... binding to basic fibroblast growth factor (FGF-2, R&D systems) and Vascular Endothelial Growth Factor 165 (VEGF165 ...
-
bioRxiv - Neuroscience 2022Quote: ... Basic fibroblast growth factor (FGF-2, 20ng/ml, R&D systems) and epidermal growth factor EGF (10ng/ml ...
-
bioRxiv - Cancer Biology 2019Quote: ... and transforming growth factor (TGF)-β1 (R&D system, MN, USA) were checked using ELISA kits ...
-
bioRxiv - Cell Biology 2021Quote: ... and vascular endothelial growth factor (VEGF; R&D Systems, MN, USA), and small molecules such as IWR-1 (Wako) ...
-
bioRxiv - Cell Biology 2021Quote: ... 200 ng/mL FGF9 (fibroblast growth factor 9; R&D Systems), and 1 μg/mL heparin (Sigma-Aldrich)) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 25 μg/mL acidic fibroblast growth factor (aFGF, R&D systems) and 100 ng/mL FGF-10 23 ...
-
bioRxiv - Molecular Biology 2023Quote: ... and growth factors: 5 ng/ml BMP-4 (R&D Systems), 9 ng/ml Activin A (R&D Systems) ...
-
bioRxiv - Bioengineering 2023Quote: ... vascular endothelial growth factor (VEGF) (R&D Systems, #293-FB/CF), epidermal growth factor (EGF ...
-
bioRxiv - Bioengineering 2023Quote: ... 200 ng/ml fibroblast growth factor 9 (FGF9; R&D Systems), and 1 μg/ml heparin (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems), and recombinant IL-34 (IL-34 ...
-
bioRxiv - Genomics 2024Quote: ... 5 mM beta-glycerophosphate and 1% insulin-transferrin-selenous acid (osteogenic media) and stimulated them the next day with recombinant human BMP2 (300 ng/ml) (R&D Systems, MN) in serum-free osteogenic media ...
-
bioRxiv - Cell Biology 2020Quote: 0.3M of purified proteins (recombinant human E-cadherin 8505 and recombinant human EGFR 344-ER R&D system) were mixed and incubated in 100μl of lysis buffer (25 mM TrisHCl pH 7.5 ...
-
bioRxiv - Bioengineering 2021Quote: ... and Human chitinase 3-like 1 (YKL-40) were purchased from R&D Systems. Bovine serum albumin was purchased from Sigma Aldrich ...
-
bioRxiv - Neuroscience 2021Quote: ... recombinant human M-CSF (R&D Systems), 100 μg/mL streptomycin ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant human TGF-β1 (R&D Systems) was used as positive control ...
-
bioRxiv - Biophysics 2021Quote: ... Recombinant Human EGF Protein (R&D Systems). Erlotinib hydrochloride (500nM ...
-
bioRxiv - Physiology 2022Quote: ... and recombinant human Norrin (R&D Systems) were used as response comparators ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant EGF protein (R&D Systems) was diluted to 10x in serum free medium ...
-
bioRxiv - Cancer Biology 2020Quote: ... Human Recombinant TGF-β1 (R&D Systems) was reconstituted in 4mM HCl ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human MMP-8 (R&D Systems) was subjected to the same conditions ...
-
bioRxiv - Immunology 2022Quote: Recombinant human Eotaxin-1 (R&D systems) and recombinant IL-5 (R&D systems ...
-
bioRxiv - Biophysics 2022Quote: ... recombinant human TGF-β1 (R&D systems) was used to induce EMT at a concentration of 2 ng/mL for 24 h ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human Interferon Gamma (R&D Systems), OADC supplement (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... and vascular endothelial growth factor (VEGF, 10 ng/ ml, R&D Systems). On day 5 EBs were dissociated and analyzed for CXCR4+ cKIT+ cells ...
-
bioRxiv - Cancer Biology 2020Quote: ... supplemented with 10 ng/mL epidermal growth factor (EGF) (R&D Systems), 1 μg/mL hydrocortisone (Sigma) ...
-
bioRxiv - Biophysics 2021Quote: ... 1 μg/mL epidermal growth factor (EGF) (R&D Systems, #236-EG10), 10 μM ionomycin (Iono ...
-
bioRxiv - Biochemistry 2022Quote: ... and 20 ng/mL fibroblast growth factor-3 (FGF3, R&D Systems) for the first 2 days and with 20 ng/mL FGF1 ...